RU2669809C2 - Способ прогноза для индивидуумов с раком предстательной железы - Google Patents

Способ прогноза для индивидуумов с раком предстательной железы Download PDF

Info

Publication number
RU2669809C2
RU2669809C2 RU2015124008A RU2015124008A RU2669809C2 RU 2669809 C2 RU2669809 C2 RU 2669809C2 RU 2015124008 A RU2015124008 A RU 2015124008A RU 2015124008 A RU2015124008 A RU 2015124008A RU 2669809 C2 RU2669809 C2 RU 2669809C2
Authority
RU
Russia
Prior art keywords
snppc
biomarkers
category
pca
combined value
Prior art date
Application number
RU2015124008A
Other languages
English (en)
Russian (ru)
Other versions
RU2015124008A (ru
Inventor
Хенрик ГРЕНБЕРГ
Мартин Эклунд
Original Assignee
Пхадиа Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пхадиа Аб filed Critical Пхадиа Аб
Publication of RU2015124008A publication Critical patent/RU2015124008A/ru
Application granted granted Critical
Publication of RU2669809C2 publication Critical patent/RU2669809C2/ru

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Software Systems (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Computation (AREA)
  • Bioethics (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Databases & Information Systems (AREA)
  • Artificial Intelligence (AREA)
  • Public Health (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
RU2015124008A 2012-11-20 2013-11-20 Способ прогноза для индивидуумов с раком предстательной железы RU2669809C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE1251310-7 2012-11-20
SE1251310 2012-11-20
SE1350602 2013-05-16
SE1350602-7 2013-05-16
PCT/EP2013/074270 WO2014079874A1 (en) 2012-11-20 2013-11-20 Prognostic method for individuals with prostate cancer

Publications (2)

Publication Number Publication Date
RU2015124008A RU2015124008A (ru) 2017-01-10
RU2669809C2 true RU2669809C2 (ru) 2018-10-16

Family

ID=49713059

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015124008A RU2669809C2 (ru) 2012-11-20 2013-11-20 Способ прогноза для индивидуумов с раком предстательной железы

Country Status (8)

Country Link
US (2) US10428385B2 (enExample)
EP (1) EP2922970B1 (enExample)
JP (1) JP2016508026A (enExample)
AU (1) AU2013349721B2 (enExample)
CA (1) CA2891394C (enExample)
ES (1) ES2694409T3 (enExample)
RU (1) RU2669809C2 (enExample)
WO (1) WO2014079874A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6308954B2 (ja) 2012-03-05 2018-04-11 オサケユキテュア・アークティック・パートナーズ・アクチボラゲットＯｙ Ａｒｃｔｉｃ Ｐａｒｔｎｅｒｓ Ａｂ 前立腺癌のリスク及び前立腺容積を予測する方法及び装置
MY182773A (en) 2012-11-20 2021-02-05 Phadia Ab Method for indicating a presence or non-presence of aggressive prostate cancer
CA2940445C (en) * 2014-03-11 2021-11-30 Phadia Ab Method for detecting a solid tumor cancer
US12326453B2 (en) 2014-03-28 2025-06-10 Opko Diagnostics, Llc Compositions and methods for active surveillance of prostate cancer
CN114740202A (zh) 2014-03-28 2022-07-12 欧普科诊断有限责任公司 与前列腺癌的诊断有关的组合物和方法
EP3253800B1 (en) 2015-03-27 2021-03-03 Opko Diagnostics, LLC Prostate antigen standards and uses thereof
CA2982262A1 (en) 2015-04-29 2016-11-03 Opko Diagnostics, Llc Compositions and methods for active surveillance of prostate cancer
JP6570929B2 (ja) * 2015-09-08 2019-09-04 国立研究開発法人農業・食品産業技術総合研究機構 特性推定モデル生成装置および方法、解析対象の特性推定装置および方法
US20190345565A1 (en) * 2017-02-01 2019-11-14 Phadia Ab Method for indicating a presence or non-presence of prostate cancer in individuals with particular characteristics
CN111712878A (zh) * 2018-01-22 2020-09-25 法迪亚股份公司 用于协调分析结果的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008096375A2 (en) * 2007-02-07 2008-08-14 Decode Genetics Ehf. Genetic variants contributing to risk of prostate cancer
WO2012031207A2 (en) * 2010-09-03 2012-03-08 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US20120202888A1 (en) 2010-10-08 2012-08-09 The Brigham And Women's Hospital, Inc. Biomarkers of prostate cancer and predicting mortality
US20120150032A1 (en) * 2010-12-13 2012-06-14 Julius Gudmundsson Sequence Variants Associated with Prostate Specific Antigen Levels
EP2850432A2 (en) 2012-05-16 2015-03-25 Phadia AB Method for indicating the presence or non-presence of prostate cancer
MY182773A (en) 2012-11-20 2021-02-05 Phadia Ab Method for indicating a presence or non-presence of aggressive prostate cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008096375A2 (en) * 2007-02-07 2008-08-14 Decode Genetics Ehf. Genetic variants contributing to risk of prostate cancer
WO2012031207A2 (en) * 2010-09-03 2012-03-08 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MARKUS A.et al.Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study//Eur Urol. 2011 Jul; 60(1): 21-28. doi: 10.1016/j.eururo.2011.01.017. *
OLAMA A. et al. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease//Hum Mol Genet. Published online 2012 Oct 12. doi: 10.1093/hmg/dds425. *
OLAMA A. et al. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease//Hum Mol Genet. Published online 2012 Oct 12. doi: 10.1093/hmg/dds425. MARKUS A.et al.Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study//Eur Urol. 2011 Jul; 60(1): 21-28. doi: 10.1016/j.eururo.2011.01.017. *

Also Published As

Publication number Publication date
US20200010912A1 (en) 2020-01-09
AU2013349721A1 (en) 2015-05-28
RU2015124008A (ru) 2017-01-10
WO2014079874A1 (en) 2014-05-30
US20150284804A1 (en) 2015-10-08
ES2694409T3 (es) 2018-12-20
CA2891394A1 (en) 2014-05-30
EP2922970B1 (en) 2018-08-08
JP2016508026A (ja) 2016-03-17
AU2013349721B2 (en) 2019-03-28
EP2922970A1 (en) 2015-09-30
US10428385B2 (en) 2019-10-01
CA2891394C (en) 2023-03-14

Similar Documents

Publication Publication Date Title
RU2675370C2 (ru) Способ выявления присутствия или отсутствия агрессивного рака предстательной железы
US20200010912A1 (en) Prognostic method for individuals with prostate cancer
RU2720148C9 (ru) Способ обнаружения солидной злокачественной опухоли
US20150094221A1 (en) Method for Indicating the Presence or Non-Presence of Prostate Cancer
JP2022179483A (ja) 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法
CN105051206B (zh) 用于指示侵袭性前列腺癌的存在或不存在的方法
HK1215594B (en) Method for indicating a presence or non-presence of aggressive prostate cancer